Table 1.
Demographic and clinical characteristics of study participants (n=128)
| Characteristic | Valuea |
|---|---|
| Age – yr | 57.2±9.7 |
| Education – no. (%) | |
| High school or less | 26 (20%) |
| Some college | 46 (36%) |
| College degree or more | 56 (44%) |
| Self-reported race – no. (%) | |
| White | 74 (58%) |
| Black | 49 (38%) |
| Other | 5 (4%) |
| Occupation – no. (%) | |
| Professional | 45 (35%) |
| Clerical or service | 20 (15%) |
| Homemaker, student, or unemployed | 11 (9%) |
| Other or unknown | 10 (8%) |
| Retired | 42 (33%) |
| Body mass index – kg/m2 | 30.5±6.4 |
| Months since cancer diagnosis | 83.3±46.3 |
| Cancer stage – no. (%) | |
| 1 | 53 (41%) |
| 2 | 1 (1%) |
| 3 | 38 (30%) |
| Data not available | 36 (28%) |
| No. of nodes removed | 15.6±8.2 |
| Chemotherapy – no. (%) | 103 (80%) |
| Radiation – no. (%) | 104 (81%) |
| Current receipt of drugs – no. (%) | |
| Tamoxifen | 16 (13%) |
| Aromatase inhibitor | 1 (1%) |
| Months since lymphedema diagnosis | 60.6±44.8 |
| Months since last lymphedema treatment | 36.2±36.2 |
| Common Toxicity Criteria Lymphedema grade – no. (%) | |
| 0 | 9 (7%) |
| 1 | 26 (20%) |
| 2 | 54 (42%) |
| 3 | 39 (31%) |
a
Continuous variables are mean ± standard deviation. Categorical variables are n (%). Percentages may not sum to 100% due to rounding error.